Literature DB >> 29378791

Pneumococcal Phenotype and Interaction with Nontypeable Haemophilus influenzae as Determinants of Otitis Media Progression.

Joseph A Lewnard1, Noga Givon-Lavi2, Paula A Tähtinen3,4, Ron Dagan2.   

Abstract

All-cause otitis media (OM) incidence has declined in numerous settings following introduction of pneumococcal conjugate vaccines (PCVs) despite increases in carriage of nonvaccine pneumococcal serotypes escaping immune pressure. To understand the basis for the declining incidence, we assessed the intrinsic capacity of pneumococcal serotypes to cause OM independently and in polymicrobial infections involving nontypeable Haemophilus influenzae (NTHi) using samples obtained from middle ear fluid and nasopharyngeal cultures before PCV7/13 rollout. Data included samples from OM episodes (11,811) submitted for cultures during a 10-year prospective study in southern Israel and nasopharyngeal samples (1,588) from unvaccinated asymptomatic children in the same population. We compared data representing pneumococcal serotype diversity across carriage and disease isolates with and without NTHi coisolation. We also measured associations between the pneumococcal phenotype and the rate of progression from colonization to OM in the presence and absence of NTHi. Whereas pneumococcal serotype diversity was lower in single-species OM than in single-species colonization, levels of serotype diversity did not differ significantly between colonization and OM in mixed-species episodes. Serotypes differed roughly 100-fold in progression rates, and those differences were attenuated in polymicrobial episodes. Vaccine serotype pneumococci had higher rates of progression than nonvaccine serotypes. While serotype invasiveness was a weak predictor of the OM progression rate, efficient capsular metabolic properties-traditionally thought to serve as an advantage in colonization-predicted an enhanced rate of progression to complex OM. The lower capacity of nonvaccine serotypes to cause OM may partially account for reductions in all-cause OM incidence despite serotype replacement in carriage following rollout of PCVs.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Streptococcus pneumoniae; nontypeable Haemophilus influenzae; otitis media; species interaction; virulence factors

Mesh:

Year:  2018        PMID: 29378791      PMCID: PMC5964529          DOI: 10.1128/IAI.00727-17

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

1.  Epidemiology of Acute Otitis Media in the Postpneumococcal Conjugate Vaccine Era.

Authors:  Ravinder Kaur; Matthew Morris; Michael E Pichichero
Journal:  Pediatrics       Date:  2017-08-07       Impact factor: 7.124

2.  Identification of Streptococcus pneumoniae and Haemophilus influenzae in culture-negative middle ear fluids from children with acute otitis media by combination of multiplex PCR and multi-locus sequencing typing.

Authors:  Qingfu Xu; Ravinder Kaur; Janet R Casey; Diana G Adlowitz; Michael E Pichichero; Mingtao Zeng
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2010-12-03       Impact factor: 1.675

3.  Improved detection of nasopharyngeal cocolonization by multiple pneumococcal serotypes by use of latex agglutination or molecular serotyping by microarray.

Authors:  Paul Turner; Jason Hinds; Claudia Turner; Auscharee Jankhot; Katherine Gould; Stephen D Bentley; François Nosten; David Goldblatt
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

4.  Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection.

Authors:  Melinda M Pettigrew; Janneane F Gent; Richard B Pyles; Aaron L Miller; Johanna Nokso-Koivisto; Tasnee Chonmaitree
Journal:  J Clin Microbiol       Date:  2011-09-07       Impact factor: 5.948

Review 5.  Co-infection subverts mucosal immunity in the upper respiratory tract.

Authors:  Rebeccah S Lijek; Jeffrey N Weiser
Journal:  Curr Opin Immunol       Date:  2012-06-02       Impact factor: 7.486

6.  Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study.

Authors:  Stefan Flasche; Albert Jan Van Hoek; Elizabeth Sheasby; Pauline Waight; Nick Andrews; Carmen Sheppard; Robert George; Elizabeth Miller
Journal:  PLoS Med       Date:  2011-04-05       Impact factor: 11.069

Review 7.  Impact of pneumococcal conjugate vaccination on otitis media: a systematic review.

Authors:  Sylvia Taylor; Paola Marchisio; Anne Vergison; Julie Harriague; William P Hausdorff; Mark Haggard
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

8.  Pneumococcal capsular polysaccharide structure predicts serotype prevalence.

Authors:  Daniel M Weinberger; Krzysztof Trzciński; Ying-Jie Lu; Debby Bogaert; Aaron Brandes; James Galagan; Porter W Anderson; Richard Malley; Marc Lipsitch
Journal:  PLoS Pathog       Date:  2009-06-12       Impact factor: 6.823

9.  Optimal serotype compositions for Pneumococcal conjugate vaccination under serotype replacement.

Authors:  Markku Nurhonen; Kari Auranen
Journal:  PLoS Comput Biol       Date:  2014-02-13       Impact factor: 4.475

Review 10.  Pneumococcal conjugate vaccines for preventing otitis media.

Authors:  Alexandre C Fortanier; Roderick P Venekamp; Chantal W B Boonacker; Eelko Hak; Anne G M Schilder; Elisabeth A M Sanders; Roger A M J Damoiseaux
Journal:  Cochrane Database Syst Rev       Date:  2014-04-02
View more
  6 in total

Review 1.  Translating Recent Microbiome Insights in Otitis Media into Probiotic Strategies.

Authors:  Marianne F L van den Broek; Ilke De Boeck; Filip Kiekens; An Boudewyns; Olivier M Vanderveken; Sarah Lebeer
Journal:  Clin Microbiol Rev       Date:  2019-07-03       Impact factor: 26.132

2.  Deconstructing Pneumococcal Progression from Colonization to Disease.

Authors:  Stephen I Pelton
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

3.  Analysing pneumococcal invasiveness using Bayesian models of pathogen progression rates.

Authors:  Alessandra Løchen; James E Truscott; Nicholas J Croucher
Journal:  PLoS Comput Biol       Date:  2022-02-17       Impact factor: 4.475

4.  Childhood vaccines and antibiotic use in low- and middle-income countries.

Authors:  Joseph A Lewnard; Nathan C Lo; Nimalan Arinaminpathy; Isabel Frost; Ramanan Laxminarayan
Journal:  Nature       Date:  2020-04-29       Impact factor: 49.962

5.  Bacterial causes of otitis media with spontaneous perforation of the tympanic membrane in the era of 13 valent pneumococcal conjugate vaccine.

Authors:  Corinne Levy; Emmanuelle Varon; Naim Ouldali; Alain Wollner; Franck Thollot; François Corrard; Andreas Werner; Stéphane Béchet; Stéphane Bonacorsi; Robert Cohen
Journal:  PLoS One       Date:  2019-02-01       Impact factor: 3.240

6.  PCV7- and PCV10-Vaccinated Otitis-Prone Children in New Zealand Have Similar Pneumococcal and Haemophilus influenzae Densities in Their Nasopharynx and Middle Ear.

Authors:  Camilla de Gier; Caitlyn M Granland; Janessa L Pickering; Tony Walls; Mejbah Bhuiyan; Nikki Mills; Peter C Richmond; Emma J Best; Ruth B Thornton; Lea-Ann S Kirkham
Journal:  Vaccines (Basel)       Date:  2019-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.